Executive Director, Business Development & Corporate Strategy

WHO WE ARE : At Dendreon, we’re transforming the battle against cancer with personalized immunotherapy. Our flagship product, PROVENGE® (sipuleucel-T) , was the first FDA-approved immunotherapy for metastatic castrate-resistant prostate cancer, utilizing a patient’s own immune cells to fight the disease. If you’re driven by the opportunity to make a meaningful impact on cancer patients’ lives, we invite you to join our team. With Immunotherapy Manufacturing Facilities in Seal Beach, CA, and Union City, GA, a talented team of scientific, clinical, regulatory, and corporate professionals based in Seal Beach, and a commercial organization operating across the United States, Dendreon continues to advance innovation in personalized cancer treatment. CORE VALUES:

Put Patients First: Every day is an opportunity to improve the lives of those living with cancer. Act with Integrity: We commit to transparency, honesty, and always doing what’s right. Build Trust: Trust is earned through candid, open communication and a collaborative approach. Raise the Bar: We embrace continuous improvement and innovation, always striving to elevate our people. Drive Results: We are accountable to each other and deliver success together. Job Summary: The Executive Director of Business Development & Corporate Strategy is a senior enterprise leader responsible for shaping and executing Dendreon’s external growth strategy (CMS). Partnering directly with the CEO and Senior Leadership Team, this role owns the identification, evaluation, prioritization, negotiation, and execution of strategic transactions, including licensing, acquisitions, investments, strategic alliances, and CDMO partnerships. The Executive Director will translate corporate objectives into an actionable business development and portfolio strategy, provide decision-quality recommendations to executive and board-level stakeholders, and lead cross-functional teams through high-stakes diligence and deal execution. This role requires a seasoned biotech or pharmaceutical business development executive with demonstrated success independently originating and closing material transactions which may include late-stage and commercial assets, complex therapeutic modalities, and global partners. Key Responsibilities: Enterprise Strategy & Portfolio Leadership

Own and lead the enterprise-wide business development and corporate strategy agenda in alignment with Dendreon’s long-range growth objectives, portfolio priorities, and capital allocation framework. Serve as a trusted strategic advisor to the CEO and Senior Leadership Team, bringing forward differentiated external growth opportunities and clear recommendations on strategic fit, value creation, risk, and prioritization. Lead portfolio-level assessments and scenario planning across licensing, acquisitions, strategic investments, alliances, and build-versus-buy opportunities. Prepare and present strategic recommendations, transaction updates, investment cases, and decision materials to executive leadership, the Board of Directors, and investment committees, as applicable.

Strategic Transactions & External Innovation

Independently originate, evaluate, prioritize, and advance a global pipeline of high-impact business development opportunities, including first-in-class and differentiated therapeutic modalities. Lead the search, evaluation, and acquisition or licensing of clinical- to commercial-stage therapeutic assets, with emphasis on late-stage Phase II/III and commercial opportunities aligned with immunotherapy, urology, oncology, and other strategic growth areas. Direct integrated scientific, clinical, regulatory, CMC, intellectual property, commercial, financial, and operational diligence; resolve critical issues and drive teams toward investment and transaction decisions. Assess complex modalities, including antibody-drug conjugates, biologics, cell therapies, and other advanced platforms, considering scientific differentiation, development risk, manufacturability, regulatory path, commercial potential, and strategic value. Build executive-level relationships with biotechnology and pharmaceutical companies, investors, venture capital and private equity firms, bankers, advisors, and other external partners to strengthen Dendreon’s access to priority opportunities.

Deal Structuring, Negotiation & Execution

Lead complex transactions from initial engagement through valuation, term sheet, negotiation, definitive agreements, governance design, closing, and transition to alliance management or integration. Develop and challenge valuation models, forecasts, risk-adjusted scenarios, transaction structures, and investment returns in partnership with Finance and other functional leaders. Lead negotiations with senior external counterparties and coordinate internal and external legal, financial, scientific, and operational advisors. Ensure clear executive alignment on deal rationale, key risks, economics, governance, decision rights, and post-transaction accountabilities.

CDMO Strategy & Commercial Growth

Own the strategic direction and business development plan for positioning Dendreon’s manufacturing capabilities as a differentiated CDMO partner. Identify and build relationships with prospective CDMO clients and strategic partners, shape value propositions, and lead the development and negotiation of proposals and commercial agreements. Partner with Technical Operations, Quality, Regulatory, Finance, and Legal to evaluate technical feasibility, capacity, economics, operational readiness, risk, and execution requirements. Represent Dendreon in senior-level client discussions, industry conferences, partnering forums, and other external engagements.

Organizational Leadership

Provide leadership, direction, and development to business development and strategy team members and cross-functional deal teams; establish clea